Location History:
- Reigate, GB (2013 - 2015)
- Surrey, GB (2016 - 2022)
Company Filing History:
Years Active: 2013-2022
Title: Zarin Brown: Innovator in Chemokine Receptor Research
Introduction
Zarin Brown is a notable inventor based in Surrey, GB, recognized for his contributions to the field of biochemistry and pharmacology. He holds a total of six patents, showcasing his innovative approach to addressing complex medical challenges.
Latest Patents
Among his latest patents are inventions related to chemokine receptor binding polypeptides. These polypeptides are specifically designed to bind to the C-X-C Motif chemokine receptor 2 (CXCR2), which plays a crucial role in various diseases. The inventions include not only the polypeptides themselves but also nucleic acids, vectors, and host cells capable of expressing these polypeptides. Furthermore, pharmaceutical compositions comprising these polypeptides are developed for treating diseases associated with aberrant functioning of CXCR2.
Career Highlights
Zarin Brown has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Ablynx NV. His work in these organizations has significantly contributed to advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Zarin has collaborated with various professionals, including Michelle Bradley and Steven John Charlton. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Zarin Brown's work in chemokine receptor research exemplifies the impact of innovative thinking in the medical field. His patents and collaborations continue to pave the way for advancements in treatment options for diseases linked to CXCR2.